drugset / Trial / NCT00607789
Study of Duloxetine vs Placebo in Treatment of Binge Eating Disorder With Depression
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this research study is to test the safety of duloxetine and see what effects (good and bad) it has on the subject's binge eating disorder and comorbid depressive disorder (depression occurring with binge eating disorder) compared to placebo (inactive pill).
Timeline
- Start
- 2006-10
- Primary completion
- 2009-10
- Completion
- 2009-10
Outcome
Missed primary endpoint
registry analysis (superiority or other test); Duloxetine Group vs Placebo Group; p <0.05; Mean Difference (Final Values) 4.3; t-test, 2 sided NCT00607789 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Duloxetine | Small molecule | 60 mg | — |
| Subject | Duloxetine | Small molecule | 120 mg | — |